• DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis

  2026-08-28

  The reference study introduces tetrahedral DNA nanostructures as an ordered interface for improving enzymatic oligonucleotide synthesis. By controlling primer orientation and spacing, the framework increases enzyme accessibility, reduces deletion errors, and supports accurate synthesis of a 60-nucleotide DNA information-storage sequence.

• Sulfisomidine Workflows for hPON1 and Microbes

  2026-08-28

  Sulfisomidine, also known as sulfamethin, supports two complementary research workflows: mechanistic hPON1 inhibition assays and bacterial folate-pathway experiments. This guide translates its mixed-type inhibition profile, formulation constraints, and assay behavior into practical protocols, controls, and troubleshooting decisions.

• Tacrolimus (FK506) at the Metabolic-Immune Interface

  2026-08-27

  Tacrolimus (FK506) is best known as a potent FKBP12–calcineurin inhibitor for T-cell and cytokine studies. New findings on the AMPK–SQSTM1/p62 antioxidant feedback loop create a useful translational question: how can a defined immune perturbation help researchers distinguish cytokine-driven effects from metabolic-stress adaptation?

• ARCA and the Next Wave of Translational mRNA

  2026-08-27

  How orientation-specific mRNA capping connects molecular design with delivery, translation, and translational decision-making in advanced research programs.

• WAY-100635: A Causal Probe for Pain Circuits

  2026-08-26

  WAY-100635 enables rigorous serotonin receptor antagonist research by testing whether 5-HT1A signaling contributes to sensory, affective, and cognitive pain phenotypes. This article translates recent cannabidiol findings into a practical, receptor-level assay strategy while defining key pharmacological limitations.

• EcYqfB and the Structural Biology of ac4C Processing

  2026-08-26

  Meng et al. define how the ASCH-domain enzyme EcYqfB hydrolyzes free N4-acetylcytidine into cytidine while showing that it does not remove ac4C from RNA. Structures of EcYqfB, mouse EOLA1, and the human TRIP4-ASCH domain further distinguish catalytic substrate recognition from broader nucleic-acid binding, providing a useful framework for RNA modification and nucleotide-processing studies.

• PNU 74654: Wnt Signaling Pathway Inhibitor

  2026-08-25

  PNU 74654 is a small-molecule Wnt signaling pathway inhibitor for mechanistic studies of Wnt/β-catenin signaling inhibition. Its defined identity, DMSO solubility, cold-storage guidance, and research-only status support controlled cancer research and stem cell research workflows.

• Poly-PR, NEAT1, and HSP70 Control of TDP-43

  2026-08-25

  Agnihotri et al. show that C9ORF72-associated poly-PR promotes NEAT1-dependent TDP-43 nuclear condensates whose material properties change over time as HSP70 first colocalizes with, and later leaves, these structures. The study provides a mechanistic framework linking stress duration, condensate fluidity, TDP-43 oligomerization, and neurotoxicity in ALS/FTD-related cellular models.

• ISRIB (trans-isomer) in Memory and ISR Research

  2026-08-24

  ISRIB (trans-isomer) connects molecular ISR control with practical ER stress, apoptosis, and inflammation-associated memory workflows. Its downstream eIF2B activity enables researchers to distinguish accelerated forgetting from impaired retrieval while supporting translational studies in neurodegenerative disease models.

• Spatially Patterned Kidney Assembloids for Disease Modeling

  2026-08-24

  Huang et al. developed mouse and human kidney progenitor assembloids that reproduce key aspects of nephron–collecting duct self-assembly, spatial organization, maturation, and function. Their in vivo-grown PKD2-deficient human model also recapitulated polycystic kidney disease features and revealed interactions among cyst epithelium, stroma, and macrophages.

• BIBR 1532: Telomerase Inhibitor Workflow

  2026-08-23

  BIBR 1532 provides a practical way to test hTERT-dependent telomerase activity, distinguish acute apoptosis from gradual telomere attrition, and design combination studies in cancer models. This workflow pairs concentration-response testing with orthogonal telomerase, transcriptional, cell-cycle, and apoptosis readouts.

• Ivermectin Beyond the Parasite: Translational Strategy

  2026-08-22

  Ivermectin is more than a familiar broad-spectrum anti-parasitic: it is a mechanistically defined research tool that can support rigorous parasitology drug development while informing carefully bounded cross-disciplinary hypotheses. This thought-leadership article connects parasite neuromuscular pharmacology with the GSDMC-driven stemness and immune-evasion biology reported in pancreatic ductal adenocarcinoma, without overstating evidence for oncology repurposing.

• TBK1, Microglial Pyroptosis, and Diabetic Neuropathy

  2026-08-21

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy through microglial pyroptosis and NLRP3 inflammasome activation. Their combination of spinal knockdown, pharmacological inhibition, behavioral testing, and tissue-level analyses supports TBK1 as a potential target for inflammation-linked diabetic pain.

• HMGCS2, Lyso-PC, and Pulmonary Fibrosis

  2026-08-20

  Yang et al. identify injured alveolar epithelial type II cells as a major source of accumulated lysophosphatidylcholine in experimental pulmonary fibrosis and connect this lipid imbalance to fibroblast activation. Their data place HMGCS2, PPARα, CPT1A, and CPT2 within an epithelial lipid-degradation pathway that may help explain how epithelial injury becomes persistent fibrotic signaling.

• SW033291: 15-PGDH Inhibition Beyond Muscle

  2026-08-20

  SW033291 is a potent 15-PGDH inhibitor for studying prostaglandin E2 elevation, hematopoietic stem cell expansion, and tissue regeneration. This guide translates enzyme and cellular potency into assay decisions while placing new muscle-repair findings in their proper experimental context.

8589 records 1/573 page Next 12345 下5页 Last page